1 option
Problem solving in cancer immunotherapy / edited by Ruth, E Board, [and three others].
- Format:
- Book
- Language:
- English
- Subjects (All):
- Oncology.
- Physical Description:
- 1 online resource (256 pages)
- Edition:
- 1st ed.
- Place of Publication:
- Oxford, England : EBN Health, [2019]
- Summary:
- Essential guide to immunotherapy for practising health professionals.
- Contents:
- Intro
- Half Title
- Title Page
- Copyright
- Contents
- Contributors
- Preface
- Acknowledgements
- Abbreviations
- Dedication
- Section One: Perspective
- 01: Immunotherapy: Past, Present and Future
- 02: Beyond Exhausted: Tumour Immune Checkpoints and Their Therapeutic Targets
- 03: Immune Checkpoint Inhibitors: Successes and Challenges
- 04: Immune-Related Toxicity of Checkpoint Inhibitors
- 05: Predicting Response to Immunotherapy
- 06: Difficulties in Assessment of PD-L1 Expression
- 07: Radiological Assessment of Immunotherapy
- 08: Combination Immunotherapies: Multimodality Treatment
- 09: Future Vaccine Strategies in Cancer Immunotherapy
- 10: Genetically-Modified Cell Therapy for Solid Tumours
- 11: Adoptive T Cell Therapy for Haematological Malignancies
- 12: Tumour-Infiltrating Lymphocytes
- Section Two: Case Study
- 01: Cytokine Release Syndrome
- 02: High-Dose Interleukin-2-Induced Myocarditis
- 03: Multiorgan Toxicity after Combination Immunotherapy in Melanoma
- 04: Immune-Related Endocrine Toxicity after Immune Checkpoint Inhibitor Therapy
- 05: Immune Checkpoint Inhibitors in Patients with Autoimmune Disease
- 06: A Patient with Lung Cancer Who Received an Immune Checkpoint Inhibitor in the First Line Setting
- 07: Sinonasal Mucosal Malignant Melanoma
- 08: Adjuvant Immunotherapy in Metastatic Melanoma
- 09: Ongoing Response after Stopping Immunotherapy
- 10: Pneumonitis after Treatment with an Anti-PD-1 Antibody in a Patient with Non-Small-Cell Lung Carcinoma
- 11: Colitis after Combination Immunotherapy in a Clinical Study of Small-Cell Lung Cancer
- 12: Jaundice after Pembrolizumab in a Patient with Melanoma and Brain Metastases
- 13: Localized Scleroderma in a Patient with Metastatic Melanoma Treated with Pembrolizumab.
- 14: Intracranial Melanoma Response to Combination Ipilimumab and Nivolumab
- 15: Delayed Response to Immunotherapy in a Patient with Acral Melanoma
- 16: Facial Nerve Palsy in a Patient with Renal Cell Carcinoma Treated with Nivolumab
- 17: Acute Kidney Injury in a Patient on Combination Immunotherapy for Metastatic Melanoma
- 18: Immune Pneumonitis after Immunotherapy for Metastatic Melanoma
- 19: A Patient with Ureteric Transitional Cell Carcinoma on Anti-PD-1 Antibody Complicated by Sarcoidosis
- 20: Renal Cell Carcinoma Treated with Ipilimumab and Nivolumab
- 21: Ocular Toxicity from Nivolumab
- 22: Multiple Immune-Related Toxicities in a Patient with Breast Cancer on Immune Checkpoint Inhibition and Chemotherapy
- 23: Oncolytic Viral Therapy: Talimogene Laherparepvec
- Index
- Back Cover.
- Notes:
- Includes index.
- Description based on print version record.
- Description based on publisher supplied metadata and other sources.
- ISBN:
- 9781739881429
- 1739881427
- OCLC:
- 1405944311
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.